This allows assessment of how much improvement persists after the peptide clears the system
In the CNS, neuroinflammation is propagated through infected monocytes, which promote the release of pro-inflammatory cytokines, such as IL-6, IL-8, IL-10, IL-2R, and TNF-, and stimulation of microglia, contributing to neuropsychiatric symptoms resulting from COVID-19 (Fig

Reduce dose or frequency if: IGF-1 exceeds the age-adjusted upper limit of normal but the patient is asymptomatic Fasting glucose rises 10 to 25 mg/dL from baseline but remains below 126 mg/dL Mild peripheral edema or joint stiffness appears and does not resolve within 2 weeks Systolic blood pressure rises 5 to 10 mmHg from baseline Discontinue CJC-1295 if: Fasting glucose exceeds 126 mg/dL on two consecutive draws IGF-1 remains above the upper limit of normal despite dose reduction New-onset carpal tunnel syndrome does not resolve after 4 weeks at reduced dose Echocardiogram shows new or worsening left ventricular hypertrophy PSA rises more than 0.75 ng/mL (annualized rate) from baseline Discontinuation should be followed by repeat labs at 4 and 8 weeks to confirm normalization
Supporting Liver Health The liver is the primary site of glutathione production and detoxification
The effects of delta-sleep-inducing peptide (DSIP) on wakefulness and sleep patterns in the cat